ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Decitabine for Injection Market Research Report 2026
Published Date: 2026-03-11
|
Report Code: QYRE-Auto-14Z17984
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Decitabine for Injection Market Research Report 2024
BUY CHAPTERS

Global Decitabine for Injection Market Research Report 2026

Code: QYRE-Auto-14Z17984
Report
2026-03-11
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sagent Pharmaceuticals
Astex Pharmaceuticals
Meitheal Pharmaceuticals
Chia Tai Tianqing Pharmaceutical Group
Hansoh Pharmaceutical
Ingenus Pharmaceutical
Xian Janssen Pharmaceutical
HUIYU PHARMACEUTICAL
Qilu Pharmaceutical

Decitabine for Injection Market

The global Decitabine for Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Decitabine for Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Decitabine for Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Decitabine for Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Decitabine for Injection include Otsuka US, Sagent Pharmaceuticals, Astex Pharmaceuticals, Meitheal Pharmaceuticals, Chia Tai Tianqing Pharmaceutical Group, Hansoh Pharmaceutical, Ingenus Pharmaceutical, Xian Janssen Pharmaceutical, Huiyu Pharmaceutical, Qilu Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Decitabine for Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Decitabine for Injection. The Decitabine for Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Decitabine for Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Decitabine for Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Decitabine for Injection Market Report

Report Metric Details
Report Name Decitabine for Injection Market
Segment by Type
  • 50mg/Bottle
  • Other
by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Otsuka US, Sagent Pharmaceuticals, Astex Pharmaceuticals, Meitheal Pharmaceuticals, Chia Tai Tianqing Pharmaceutical Group, Hansoh Pharmaceutical, Ingenus Pharmaceutical, Xian Janssen Pharmaceutical, Huiyu Pharmaceutical, Qilu Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Decitabine for Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Decitabine for Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Decitabine for Injection Market report?

Ans: The main players in the Decitabine for Injection Market are Otsuka US, Sagent Pharmaceuticals, Astex Pharmaceuticals, Meitheal Pharmaceuticals, Chia Tai Tianqing Pharmaceutical Group, Hansoh Pharmaceutical, Ingenus Pharmaceutical, Xian Janssen Pharmaceutical, Huiyu Pharmaceutical, Qilu Pharmaceutical

What are the Application segmentation covered in the Decitabine for Injection Market report?

Ans: The Applications covered in the Decitabine for Injection Market report are Hospital, Clinic

What are the Type segmentation covered in the Decitabine for Injection Market report?

Ans: The Types covered in the Decitabine for Injection Market report are 50mg/Bottle, Other

1 Decitabine for Injection Market Overview
1.1 Product Definition
1.2 Decitabine for Injection by Type
1.2.1 Global Decitabine for Injection Market Value by Type: 2025 vs 2032
1.2.2 50mg/Bottle
1.2.3 Other
1.3 Decitabine for Injection by Application
1.3.1 Global Decitabine for Injection Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Decitabine for Injection Market Size Estimates and Forecasts
1.4.1 Global Decitabine for Injection Revenue 2021–2032
1.4.2 Global Decitabine for Injection Sales 2021–2032
1.4.3 Global Decitabine for Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Decitabine for Injection Market Competition by Manufacturers
2.1 Global Decitabine for Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Decitabine for Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Decitabine for Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Decitabine for Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Decitabine for Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Decitabine for Injection, Product Types and Applications
2.7 Global Key Manufacturers of Decitabine for Injection, Date of Entry into the Industry
2.8 Global Decitabine for Injection Market Competitive Situation and Trends
2.8.1 Global Decitabine for Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Decitabine for Injection Players Market Share by Revenue
2.8.3 Global Decitabine for Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Decitabine for Injection Market Scenario by Region
3.1 Global Decitabine for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Decitabine for Injection Sales by Region: 2021–2032
3.2.1 Global Decitabine for Injection Sales by Region: 2021–2026
3.2.2 Global Decitabine for Injection Sales by Region: 2027–2032
3.3 Global Decitabine for Injection Revenue by Region: 2021–2032
3.3.1 Global Decitabine for Injection Revenue by Region: 2021–2026
3.3.2 Global Decitabine for Injection Revenue by Region: 2027–2032
3.4 North America Decitabine for Injection Market Facts & Figures by Country
3.4.1 North America Decitabine for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Decitabine for Injection Sales by Country (2021–2032)
3.4.3 North America Decitabine for Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Decitabine for Injection Market Facts & Figures by Country
3.5.1 Europe Decitabine for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Decitabine for Injection Sales by Country (2021–2032)
3.5.3 Europe Decitabine for Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Decitabine for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Decitabine for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Decitabine for Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Decitabine for Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Decitabine for Injection Market Facts & Figures by Country
3.7.1 Latin America Decitabine for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Decitabine for Injection Sales by Country (2021–2032)
3.7.3 Latin America Decitabine for Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Decitabine for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Decitabine for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Decitabine for Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Decitabine for Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Decitabine for Injection Sales by Type (2021–2032)
4.1.1 Global Decitabine for Injection Sales by Type (2021–2026)
4.1.2 Global Decitabine for Injection Sales by Type (2027–2032)
4.1.3 Global Decitabine for Injection Sales Market Share by Type (2021–2032)
4.2 Global Decitabine for Injection Revenue by Type (2021–2032)
4.2.1 Global Decitabine for Injection Revenue by Type (2021–2026)
4.2.2 Global Decitabine for Injection Revenue by Type (2027–2032)
4.2.3 Global Decitabine for Injection Revenue Market Share by Type (2021–2032)
4.3 Global Decitabine for Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Decitabine for Injection Sales by Application (2021–2032)
5.1.1 Global Decitabine for Injection Sales by Application (2021–2026)
5.1.2 Global Decitabine for Injection Sales by Application (2027–2032)
5.1.3 Global Decitabine for Injection Sales Market Share by Application (2021–2032)
5.2 Global Decitabine for Injection Revenue by Application (2021–2032)
5.2.1 Global Decitabine for Injection Revenue by Application (2021–2026)
5.2.2 Global Decitabine for Injection Revenue by Application (2027–2032)
5.2.3 Global Decitabine for Injection Revenue Market Share by Application (2021–2032)
5.3 Global Decitabine for Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Otsuka US
6.1.1 Otsuka US Company Information
6.1.2 Otsuka US Description and Business Overview
6.1.3 Otsuka US Decitabine for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Otsuka US Decitabine for Injection Product Portfolio
6.1.5 Otsuka US Recent Developments/Updates
6.2 Sagent Pharmaceuticals
6.2.1 Sagent Pharmaceuticals Company Information
6.2.2 Sagent Pharmaceuticals Description and Business Overview
6.2.3 Sagent Pharmaceuticals Decitabine for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Sagent Pharmaceuticals Decitabine for Injection Product Portfolio
6.2.5 Sagent Pharmaceuticals Recent Developments/Updates
6.3 Astex Pharmaceuticals
6.3.1 Astex Pharmaceuticals Company Information
6.3.2 Astex Pharmaceuticals Description and Business Overview
6.3.3 Astex Pharmaceuticals Decitabine for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Astex Pharmaceuticals Decitabine for Injection Product Portfolio
6.3.5 Astex Pharmaceuticals Recent Developments/Updates
6.4 Meitheal Pharmaceuticals
6.4.1 Meitheal Pharmaceuticals Company Information
6.4.2 Meitheal Pharmaceuticals Description and Business Overview
6.4.3 Meitheal Pharmaceuticals Decitabine for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Meitheal Pharmaceuticals Decitabine for Injection Product Portfolio
6.4.5 Meitheal Pharmaceuticals Recent Developments/Updates
6.5 Chia Tai Tianqing Pharmaceutical Group
6.5.1 Chia Tai Tianqing Pharmaceutical Group Company Information
6.5.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
6.5.3 Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Product Portfolio
6.5.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
6.6 Hansoh Pharmaceutical
6.6.1 Hansoh Pharmaceutical Company Information
6.6.2 Hansoh Pharmaceutical Description and Business Overview
6.6.3 Hansoh Pharmaceutical Decitabine for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hansoh Pharmaceutical Decitabine for Injection Product Portfolio
6.6.5 Hansoh Pharmaceutical Recent Developments/Updates
6.7 Ingenus Pharmaceutical
6.7.1 Ingenus Pharmaceutical Company Information
6.7.2 Ingenus Pharmaceutical Description and Business Overview
6.7.3 Ingenus Pharmaceutical Decitabine for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ingenus Pharmaceutical Decitabine for Injection Product Portfolio
6.7.5 Ingenus Pharmaceutical Recent Developments/Updates
6.8 Xian Janssen Pharmaceutical
6.8.1 Xian Janssen Pharmaceutical Company Information
6.8.2 Xian Janssen Pharmaceutical Description and Business Overview
6.8.3 Xian Janssen Pharmaceutical Decitabine for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Xian Janssen Pharmaceutical Decitabine for Injection Product Portfolio
6.8.5 Xian Janssen Pharmaceutical Recent Developments/Updates
6.9 Huiyu Pharmaceutical
6.9.1 Huiyu Pharmaceutical Company Information
6.9.2 Huiyu Pharmaceutical Description and Business Overview
6.9.3 Huiyu Pharmaceutical Decitabine for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Huiyu Pharmaceutical Decitabine for Injection Product Portfolio
6.9.5 Huiyu Pharmaceutical Recent Developments/Updates
6.10 Qilu Pharmaceutical
6.10.1 Qilu Pharmaceutical Company Information
6.10.2 Qilu Pharmaceutical Description and Business Overview
6.10.3 Qilu Pharmaceutical Decitabine for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Qilu Pharmaceutical Decitabine for Injection Product Portfolio
6.10.5 Qilu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Decitabine for Injection Industry Chain Analysis
7.2 Decitabine for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Decitabine for Injection Production Mode & Process Analysis
7.4 Decitabine for Injection Sales and Marketing
7.4.1 Decitabine for Injection Sales Channels
7.4.2 Decitabine for Injection Distributors
7.5 Decitabine for Injection Customer Analysis
8 Decitabine for Injection Market Dynamics
8.1 Decitabine for Injection Industry Trends
8.2 Decitabine for Injection Market Drivers
8.3 Decitabine for Injection Market Challenges
8.4 Decitabine for Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sagent Pharmaceuticals
Astex Pharmaceuticals
Meitheal Pharmaceuticals
Chia Tai Tianqing Pharmaceutical Group
Hansoh Pharmaceutical
Ingenus Pharmaceutical
Xian Janssen Pharmaceutical
HUIYU PHARMACEUTICAL
Qilu Pharmaceutical
List of Tables
 Table 1. Global Decitabine for Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Decitabine for Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Decitabine for Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Decitabine for Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Decitabine for Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Decitabine for Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Decitabine for Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Decitabine for Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Decitabine for Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Decitabine for Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Decitabine for Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Decitabine for Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Decitabine for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Decitabine for Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Decitabine for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Decitabine for Injection Sales by Region (K Units), 2021–2026
 Table 18. Global Decitabine for Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Decitabine for Injection Sales by Region (K Units), 2027–2032
 Table 20. Global Decitabine for Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Decitabine for Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Decitabine for Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Decitabine for Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Decitabine for Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Decitabine for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Decitabine for Injection Sales by Country (K Units), 2021–2026
 Table 27. North America Decitabine for Injection Sales by Country (K Units), 2027–2032
 Table 28. North America Decitabine for Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Decitabine for Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Decitabine for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Decitabine for Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe Decitabine for Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe Decitabine for Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Decitabine for Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Decitabine for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Decitabine for Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Decitabine for Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Decitabine for Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Decitabine for Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Decitabine for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Decitabine for Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America Decitabine for Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America Decitabine for Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Decitabine for Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Decitabine for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Decitabine for Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Decitabine for Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Decitabine for Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Decitabine for Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Decitabine for Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global Decitabine for Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global Decitabine for Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Decitabine for Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Decitabine for Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Decitabine for Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Decitabine for Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Decitabine for Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Decitabine for Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Decitabine for Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Decitabine for Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global Decitabine for Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global Decitabine for Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Decitabine for Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Decitabine for Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Decitabine for Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Decitabine for Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Decitabine for Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Decitabine for Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Decitabine for Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. Otsuka US Company Information
 Table 71. Otsuka US Description and Business Overview
 Table 72. Otsuka US Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Otsuka US Decitabine for Injection Product
 Table 74. Otsuka US Recent Developments/Updates
 Table 75. Sagent Pharmaceuticals Company Information
 Table 76. Sagent Pharmaceuticals Description and Business Overview
 Table 77. Sagent Pharmaceuticals Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Sagent Pharmaceuticals Decitabine for Injection Product
 Table 79. Sagent Pharmaceuticals Recent Developments/Updates
 Table 80. Astex Pharmaceuticals Company Information
 Table 81. Astex Pharmaceuticals Description and Business Overview
 Table 82. Astex Pharmaceuticals Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Astex Pharmaceuticals Decitabine for Injection Product
 Table 84. Astex Pharmaceuticals Recent Developments/Updates
 Table 85. Meitheal Pharmaceuticals Company Information
 Table 86. Meitheal Pharmaceuticals Description and Business Overview
 Table 87. Meitheal Pharmaceuticals Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Meitheal Pharmaceuticals Decitabine for Injection Product
 Table 89. Meitheal Pharmaceuticals Recent Developments/Updates
 Table 90. Chia Tai Tianqing Pharmaceutical Group Company Information
 Table 91. Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
 Table 92. Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Product
 Table 94. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
 Table 95. Hansoh Pharmaceutical Company Information
 Table 96. Hansoh Pharmaceutical Description and Business Overview
 Table 97. Hansoh Pharmaceutical Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Hansoh Pharmaceutical Decitabine for Injection Product
 Table 99. Hansoh Pharmaceutical Recent Developments/Updates
 Table 100. Ingenus Pharmaceutical Company Information
 Table 101. Ingenus Pharmaceutical Description and Business Overview
 Table 102. Ingenus Pharmaceutical Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Ingenus Pharmaceutical Decitabine for Injection Product
 Table 104. Ingenus Pharmaceutical Recent Developments/Updates
 Table 105. Xian Janssen Pharmaceutical Company Information
 Table 106. Xian Janssen Pharmaceutical Description and Business Overview
 Table 107. Xian Janssen Pharmaceutical Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Xian Janssen Pharmaceutical Decitabine for Injection Product
 Table 109. Xian Janssen Pharmaceutical Recent Developments/Updates
 Table 110. Huiyu Pharmaceutical Company Information
 Table 111. Huiyu Pharmaceutical Description and Business Overview
 Table 112. Huiyu Pharmaceutical Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Huiyu Pharmaceutical Decitabine for Injection Product
 Table 114. Huiyu Pharmaceutical Recent Developments/Updates
 Table 115. Qilu Pharmaceutical Company Information
 Table 116. Qilu Pharmaceutical Description and Business Overview
 Table 117. Qilu Pharmaceutical Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Qilu Pharmaceutical Decitabine for Injection Product
 Table 119. Qilu Pharmaceutical Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Decitabine for Injection Distributors List
 Table 123. Decitabine for Injection Customers List
 Table 124. Decitabine for Injection Market Trends
 Table 125. Decitabine for Injection Market Drivers
 Table 126. Decitabine for Injection Market Challenges
 Table 127. Decitabine for Injection Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Decitabine for Injection
 Figure 2. Global Decitabine for Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Decitabine for Injection Market Share by Type: 2025 & 2032
 Figure 4. 50mg/Bottle Product Picture
 Figure 5. Other Product Picture
 Figure 6. Global Decitabine for Injection Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Decitabine for Injection Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Decitabine for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Decitabine for Injection Market Size (US$ Million), 2021–2032
 Figure 12. Global Decitabine for Injection Sales (K Units), 2021–2032
 Figure 13. Global Decitabine for Injection Average Price (US$/Unit), 2021–2032
 Figure 14. Decitabine for Injection Report Years Considered
 Figure 15. Decitabine for Injection Sales Share by Manufacturers in 2025
 Figure 16. Global Decitabine for Injection Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Decitabine for Injection Players: Market Share by Revenue in Decitabine for Injection in 2025
 Figure 18. Decitabine for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Decitabine for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Decitabine for Injection Sales Market Share by Country (2021–2032)
 Figure 21. North America Decitabine for Injection Revenue Market Share by Country (2021–2032)
 Figure 22. United States Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Decitabine for Injection Sales Market Share by Country (2021–2032)
 Figure 25. Europe Decitabine for Injection Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Decitabine for Injection Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Decitabine for Injection Revenue Market Share by Region (2021–2032)
 Figure 33. China Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Decitabine for Injection Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Decitabine for Injection Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Decitabine for Injection Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Decitabine for Injection Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Decitabine for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Decitabine for Injection by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Decitabine for Injection by Type (2021–2032)
 Figure 53. Global Decitabine for Injection Price (US$/Unit) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Decitabine for Injection by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Decitabine for Injection by Application (2021–2032)
 Figure 56. Global Decitabine for Injection Price (US$/Unit) by Application (2021–2032)
 Figure 57. Decitabine for Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Azacitidine Injection Market Research Report 2024
Global Gadodiamide Injection Market Research Report 2024
Global Mitomycin for Injection Market Research Report 2024
Global Bevacizumab Injection Market Research Report 2024
Global Epigenetic Therapeutics Market Research Report 2024
Global Inosine Injection Market Research Report 2024
Global Hydroxylcamptothecine Injection Market Research Report 2024
Global Sterile Injection Development Market Research Report 2025
Global Cyclophosphamide for Injection Market Research Report 2024
Global Programmable Injector Market Research Report 2025
Global Iopromide Injection Market Research Report 2024
Global Lacosamide Injection Market Research Report 2024
Global Bortezomib for Injection Market Research Report 2025
Global Epigenetic Kits Market Research Report 2024
Global Special Injection Market Research Report 2025
Global Vidarabine Monophosphate for Injection Market Research Report 2024
Global Epigenome Sequencing Market Research Report 2024
Global Eye Injection Market Research Report 2024
Global Thymofaxine Injection Market Research Report 2024
Global Ivonescimab Injection Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions